Completed NA INTERVENTIONAL 2-arm NCT02201498

Randomized Clinical Trial for Primary Molar Pulpotomy, Biodentine Vs Formocresol-ZOE

A New Technique for Primary Molar Pulpotomy : A Randomized Clinical Trial Comparing the Radiographic and Clinical Success of the Formocresol-zinc Oxide Eugenol Technique and the Biodentine Technique

Sponsor: Septodont

Conditions Deep Dental Caries

Interventions Pulpotomies with Formocresol/OZE and Biodentine

Updated 6 times since 2017 Last updated: Jan 10, 2018 Started: Sep 30, 2014 Primary completion: Jun 30, 2016 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02201498, this NA trial focuses on Deep Dental Caries and remains completed. Sponsored by Septodont, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2018 — Jun 2018 [monthly]

Completed NA

Status: Unknown Status → Completed

▶ Show 1 earlier version

Jan 2017 — Feb 2018 [monthly]

Unknown Status NA

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Septodont
St. Justine's Hospital
Université de Montréal

Data source: Université de Montréal

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada